POTASSIUM CITRATE
Generic: POTASSIUM CITRATE
Upsher-Smith LaboratoriesManufacturer
ORALRoute
POTASSIUM CITRATEActive Substance
1985-08-30Original Approval
POTASSIUM CITRATE is FDA application NDA019071, sponsored by MISSION PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2018-07-18
Potassium Citrate Extended-Release Tablets, USP, 10 mEq, 100-count bottles, Rx only, Manufactured for: Vensun PharmaceutFailed Tablet/Capsule Specifications: Tablet breakage
Class II2018-07-18
Potassium Citrate Extended-Release Tablets, USP, 15 mEq, 100-count bottles, Rx only, Manufactured for: Vensun PharmaceutFailed Tablet/Capsule Specifications: Tablet breakage
Top Reported Reactions
1
DRUG INEFFECTIVE
428 reports
2
FATIGUE
350 reports
3
DIARRHOEA
315 reports
4
NAUSEA
302 reports
5
PAIN
290 reports
6
OFF LABEL USE
257 reports
7
NEPHROLITHIASIS
248 reports
8
DIZZINESS
226 reports
9
DYSPNOEA
213 reports
10
HEADACHE
199 reports